En-Bio Technology's microsatellite analysis patented in 17 countries
Published: 2004-10-29 06:57:00
Updated: 2004-10-29 06:57:00
En-Bio Technology said on October 26 that Cangen Biotechnologies Inc. has acquired a patent for its platform microsatellite analysis (MSA) technology from 17 countries from Australia. The Korean company acquired a larger share in Cangen last year.
Cangen has focused its initial efforts on deve...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.